Methyl Linoleate

CAS No. 112-63-0

Methyl Linoleate( —— )

Catalog No. M17829 CAS No. 112-63-0

Methyl linoleate has antioxidant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl Linoleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl linoleate has antioxidant activity.
  • Description
    Methyl linoleate has antioxidant activity. (In Vitro):Sageretia thea fruit extracts rich in Methyl linoleate downregulate melanogenesis via the Akt/GSK3β signaling pathway. The HFSF and Methyl linoleate inhibit β-catenin-mediated transcriptional activation of MITF through the Akt/GSK3β signaling pathway.
  • In Vitro
    Sageretia thea?fruit extracts rich in Methyl linoleate downregulate melanogenesis via the Akt/GSK3β signaling pathway. The HFSF and Methyl linoleate inhibit β-catenin-mediated transcriptional activation of?MITF?through the Akt/GSK3β signaling pathway.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cholecystokinin Receptor
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112-63-0
  • Formula Weight
    294.47
  • Molecular Formula
    C19H34O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (282.98 mM)
  • SMILES
    CCCCCC=CCC=CCCCCCCCC(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-Cbz-DL-tryptophan

    N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.

  • GV150013

    GV150013 is an antagonist of cholecystokinin-2 (CCK2) receptor.

  • Netazepide

    Netazepide (YF476, Sograzepide)?is a potent, selective and orally active gastrin/CCK-2 antagonist with IC50 of 0.1 nM.